• Reliance Industries: Reliance New Energy Solar, a subsidiary of the company, has acquired REC Solar Holdings AS from China National Bluestar Co for an enterprise value of $771 million. REC Solar is one of the world’s leading solar cell, panels and polysilicon manufacturer.

  • Tata Motors: Jaguar Land Rover Q2 FY22 retail sales continued to be constrained by the impact of the global semiconductor shortage on production, with wholesales for the period in line with July guidance. Retail sales were down 18.4% year-on-year at 92,710 vehicles Vs 1,13,569 vehicles. Wholesales totalled 64,032 units (excluding the China JV), down 12.8% YoY.

  • Tata Group stocks: Tata Sons emerged as the winning bidder of Air India. It made an offer of Rs 18,000 crore. The reserve price was Rs 12,906 crore. Tata Group will get 100% stake in Air India, including its wholly owned subsidiary Air India Express, and 50% in ground handling unit Air India SATS Airports Services Pvt.

  • Maruti Suzuki India: Total production in September down 51.06% to 81,278 units Vs 1,66,086 units last year.

  • GOCL Corporation: IDL Explosives, a subsidiary of company, has bagged order of Rs 592.45 crore from Coal India, for supply of bulk explosives, to be supplied over a period of 2 years.

  • Cadila Healthcare: Fortress Biotech partner company Cyprium Therapeutics, with support from its licensing partner Sentynl Therapeutics, has announced positive results from an efficacy and safety analysis of data integrated from two completed pivotal studies in patients with Menkes disease treated with CUTX-101, copper histidinate.

  • Jubilant Ingrevia: To acquire of 26.60% stake in AMP Energy Green Fifteen for Rs 5.11 crore. The acquisition is expected to be completed in six months. The company has acquired stake in AMP to put up solar power plant with capacity of 15.5 MW under captive scheme.

  • Gujarat Pipavav Port: Q2 container volume down 6.54% year-on-year at 157 TEUs versus 168 TEUs. Dry bulk volume up 52.74% at 1.39 MT Vs 0.91 MT.

  • Equitas Small Finance Bank: Provisional Q2 FY22 CASA Ratio at 45% compared to 40% in Q1. Total deposits up 6% at Rs 18,094 crore Vs Rs 17,095 crore. Gross Advances at Rs 18,981 crore Vs Rs 17,837 crore.

  • Adani Total Gas: The company has forayed into compressed bio-gas business. It has signed a definitive agreement with Shri Mataji Gauvansh Seva Sansthan for exclusively collaborating on the establishment of a bio-conversion plant with a design capacity of about 350 tonnes per day of feed processing at Mathura, Uttar Pradesh based on cattle dung as the primary biomass along with other biomass including napier grass, press mud, etc.

  • TCS: Board has approved the re-appointment of Rajesh Gopinathan as CEO and MD for a term of five years from February 21, 2022.

  • RITES: The company has named Rahul Mithal as Chairman and MD.

  • Gland Pharma: The company has received tentative approval from the U.S. FDA for Sugammadex Injection. The injection is used to reverse the effects of the muscle relaxants Rocuronium Bromide and Vecuronium Bromide given to patients during surgery.

  • Bank of Maharashtra: The bank has reduced Marginal Cost of Funds Based Lending Rate by 0.10% across tenors. The Repo Rate Linked Lending Rate has been revised from 6.90% to 6.80% w.e.f. October 11.

  • Earnings: Delta Corp, HFCL, Krsnaa Diagnostics, Ramkrishna Forgings, Saregama India, Tata Metaliks, Tinplate Company of India.